MAHs’ Principal Responsibilities for Safety Risk during the Whole-life Cycle of Drugs
ZHONG Lumiao
Chinese Journal of Pharmacovigilance . 2019, (11): 666 -669 .  DOI: 10.19803/j.1672-8629.2019.11.05